Medical News

RSS

Somnus Therapeutics completes SKP-1041 Phase 2 trial against sleep maintenance insomnia

Somnus Therapeutics, Inc., a private specialty pharmaceutical company, has completed a Phase 2 dose-ranging study of SKP-1041, a modified-release formulation of zaleplon.

2 Jun 2011

XTL receives FDA Orphan-drug designation for rHuEPO drug to treat Multiple Myeloma

On May 29, 2011 XTL has announced that its rHuEPO drug which is currently in preparations for phase 2 clinical trial, has been granted an Orphan-drug designation by the US Food and Drug Administration (FDA) for treatment of Multiple Myeloma blood cancer.

2 Jun 2011

Fero Industries completes Sucanon human clinical trials on Type-2 diabetes

Fero Industries, Inc. is pleased to announce that independent human clinical trials of Sucanon have been successfully completed in the Middle East.

2 Jun 2011

Viewpoints: More on Medicare's 'hard choices'; elderly and anti-psychotics; Calif. insurance rate hikes

Unless we make hard decisions now, in less than a decade every dollar of federal revenue will go to covering the costs of Medicare, Social Security and interest payments on our debt. ... I admire Congressman Paul Ryan's honest attempt to save Medicare.

2 Jun 2011

Kindred acquires RehabCare

Kindred Healthcare, Inc. announced that it has completed the previously announced acquisition of RehabCare Group, Inc.

2 Jun 2011

IMRT cuts GI side effects from prostate cancer in half vs. 3D-CRT

Intensity modulated radiation therapy, a newer, more precise form of radiation therapy, causes fewer gastrointestinal side effects when combined with hormone therapy than using three-dimensional radiation therapy, according to a study published in the June issue of the International Journal of Radiation Oncology·Biology·Physics, the official scientific journal of the American Society for Radiation Oncology (ASTRO).

1 Jun 2011

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Adaptimmune announced that it has opened a Phase I/II, dual site, two-cohort, open-label clinical trial in multiple myeloma at the University of Maryland and the University of Pennsylvania testing its enhanced T cell receptor T cell therapy.

1 Jun 2011

Men with migraine suffer from PTSD than women

A recently published paper highlights that while the risk of post-traumatic stress disorder (PTSD) is more common in those with migraine than those without migraine irrespective of sex, the risk is greater in male migraineurs than female migraineurs. Study details are now available in Headache: The Journal of Head and Face Pain, published by Wiley-Blackwell on behalf of the American Headache Society.

1 Jun 2011

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

Preliminary results of a Phase II single-arm study to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting showed that Eisai's lenvatinib demonstrated an Objective Response Rate of 59% (34/58, 95% CI: 45-71), based on an updated investigator assessment, in patients with advanced radioiodine (RAI)-refractory differentiated thyroid cancer.

1 Jun 2011

China's SFDA grants production license to TPI anti-diabetic drug Gliclazide

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals today announced TPI has received the production license for its anti-diabetic drug Gliclazide Tablets from China's State Food and Drug Administration.

1 Jun 2011

The Eden Alternative, WellAWARE Systems partner to improve Elder care

WellAWARE Systems, the developer of breakthrough technology designed to enable proactive and preventive Elder care, today announced a new partnership with international not-for-profit organization, The Eden Alternative.

1 Jun 2011

First Edition: June 1, 2011

Kaiser Health News staff writer Phil Galewitz reports: "Trying to spur enrollment in a key new benefit of the 2010 health law, the Obama administration announced today it is slashing premiums for new high-risk insurance plans and no longer requiring applicants to submit a rejection letter from private insurers".

1 Jun 2011

Medical Illumination, Bovie sign exclusive distribution agreement for new LED lights

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced that it has entered into an exclusive agreement with Medical Illumination International, Inc. San Fernando, CA to bring a new generation of medical lighting to the medical community in the United States.

1 Jun 2011

New study: Low-carb, higher-fat diets do not harm vascular health

Overweight and obese people looking to drop some pounds and considering one of the popular low-carbohydrate diets, along with moderate exercise, need not worry that the higher proportion of fat in such a program compared to a low-fat, high-carb diet may harm their arteries, suggests a pair of new studies by heart and vascular researchers at Johns Hopkins.

1 Jun 2011

Scientists discover key biological mechanism underpinning transition to alcohol dependence

A team of Scripps Research Institute scientists has found a key biological mechanism underpinning the transition to alcohol dependence. This finding opens the door to the development of drugs to manage excessive alcohol consumption.

1 Jun 2011

HHS announces new steps to decrease premiums and help insure more Americans

The U.S. Department of Health and Human Services today announced new steps to reduce premiums and make it easier for Americans to enroll in the Pre-Existing Condition Insurance Plan. Premiums for the Federally-administered Pre-Existing Condition Insurance Plan will drop as much as 40 percent in 18 States, and eligibility standards will be eased in 23 States and the District of Columbia to ensure more Americans with pre-existing conditions have access to affordable health insurance.

1 Jun 2011

$IOF position paper recommends coordinator-based models to manage fragility fracture patients$

IOF position paper recommends coordinator-based models to manage fragility fracture patients

A prior fracture at least doubles a patient's future fracture risk - yet numerous studies from across the world have found that healthcare systems fail to respond to the first fracture to prevent future fractures.

1 Jun 2011

EMA accepts Pfizer's filing of axitinib for regulatory review to treat advanced renal cell carcinoma

Pfizer Inc. announced today that the European Medicines Agency has accepted Pfizer's filing for regulatory review of axitinib for patients with advanced renal cell carcinoma after failure of prior systemic treatment.

1 Jun 2011

Campbell Soup Foundation to kick off 37th annual summer program in nutrition education

Campbell Soup Foundation, the philanthropic arm of the Campbell Soup Company, will kick off its 37th annual Campbell Soup Summer Program on Thursday, June 2, 2011.

1 Jun 2011

FTC accepts Grifols and Talecris' Consent Agreement for public comment

Grifols, S.A. and Talecris Biotherapeutics Holdings Corp. announced today that the U.S. Federal Trade Commission has accepted for public comment a Consent Agreement that outlines the conditions necessary for Grifols' acquisition of Talecris to proceed.

1 Jun 2011

Medical News

Somnus Therapeutics completes SKP-1041 Phase 2 trial against sleep maintenance insomnia

XTL receives FDA Orphan-drug designation for rHuEPO drug to treat Multiple Myeloma

Fero Industries completes Sucanon human clinical trials on Type-2 diabetes

Viewpoints: More on Medicare's 'hard choices'; elderly and anti-psychotics; Calif. insurance rate hikes

Kindred acquires RehabCare

IMRT cuts GI side effects from prostate cancer in half vs. 3D-CRT

Adaptimmune announces opening of Phase I/II clinical trial in multiple myeloma

Men with migraine suffer from PTSD than women

Preliminary results from Eisai's lenvatinib Phase II trial in thyroid cancer to be presented at ASCO 2011

China's SFDA grants production license to TPI anti-diabetic drug Gliclazide

The Eden Alternative, WellAWARE Systems partner to improve Elder care

First Edition: June 1, 2011

Medical Illumination, Bovie sign exclusive distribution agreement for new LED lights

New study: Low-carb, higher-fat diets do not harm vascular health

Scientists discover key biological mechanism underpinning transition to alcohol dependence

HHS announces new steps to decrease premiums and help insure more Americans

IOF position paper recommends coordinator-based models to manage fragility fracture patients

EMA accepts Pfizer's filing of axitinib for regulatory review to treat advanced renal cell carcinoma

Campbell Soup Foundation to kick off 37th annual summer program in nutrition education

FTC accepts Grifols and Talecris' Consent Agreement for public comment

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News